| | Reviews Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE®) in the management of hemophilia A Amy D Shapiro Vasc Health Risk Manag. 2007 October; 3(5): 555–565. PMCID: PMC2291300 The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation Paolo Gelosa, Mauro Cimino, Alice Pignieri, Elena Tremoli, Uliano Guerrini, and Luigi Sironi Vasc Health Risk Manag. 2007 October; 3(5): 567–577. PMCID: PMC2291301 Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension John D Bisognano, Trent McLaughlin, Craig S Roberts, and Simon SK Tang Vasc Health Risk Manag. 2007 October; 3(5): 579–585. PMCID: PMC2291302 Comprehensive cardiovascular risk management – what does it mean in practice? Leif Erhardt, Robert Moller, and Juan García Puig Vasc Health Risk Manag. 2007 October; 3(5): 587–603. PMCID: PMC2291303 Aldosterone antagonism in heart failure Alan B Miller Vasc Health Risk Manag. 2007 October; 3(5): 605–609. PMCID: PMC2291304 Are pleiotropic effects of statins real? Alberto Corsini, Nicola Ferri, and Michele Cortellaro Vasc Health Risk Manag. 2007 October; 3(5): 611–613. PMCID: PMC2291305 Cholesterol lowering for secondary prevention: What statin dose should we use? Kiranbir Josan and Finlay A McAlister Vasc Health Risk Manag. 2007 October; 3(5): 615–627. PMCID: PMC2291306 Ischemic preconditioning: Protection against myocardial necrosis and apoptosis Efstathios K Iliodromitis, Antigone Lazou, and Dimitrios Th Kremastinos Vasc Health Risk Manag. 2007 October; 3(5): 629–637. PMCID: PMC2291307 A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus WH Wilson Tang Vasc Health Risk Manag. 2007 October; 3(5): 639–645. PMCID: PMC2291308 Nebivolol in the treatment of chronic heart failure Angie Veverka and Jennifer L Salinas Vasc Health Risk Manag. 2007 October; 3(5): 647–654. PMCID: PMC2291309 Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia Man-Chiu Poon Vasc Health Risk Manag. 2007 October; 3(5): 655–664. PMCID: PMC2291310 Optimizing combination treatment in the management of type 2 diabetes Giuseppe Derosa and Salvadeo Sibilla Vasc Health Risk Manag. 2007 October; 3(5): 665–671. PMCID: PMC2291311 Cardiovascular disease and osteoporosis: Balancing risk management Darren ER Warburton, Crystal Whitney Nicol, Stephanie N Gatto, and Shannon SD Bredin Vasc Health Risk Manag. 2007 October; 3(5): 673–689. PMCID: PMC2291312 Utilizing enoxaparin in the management of STEMI Andrea Rubboli, Alessandro Capecchi, and Giuseppe Di Pasquale Vasc Health Risk Manag. 2007 October; 3(5): 691–700. PMCID: PMC2291313 Management of intracerebral hemorrhage Ramandeep Sahni and Jesse Weinberger Vasc Health Risk Manag. 2007 October; 3(5): 701–709. PMCID: PMC2291314 Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin FD Richard Hobbs Vasc Health Risk Manag. 2007 October; 3(5): 711–719. PMCID: PMC2291315 A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes Mozhgan Dorkhan and Anders Frid Vasc Health Risk Manag. 2007 October; 3(5): 721–731. PMCID: PMC2291316 Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors Harold Bays and Peter H Jones Vasc Health Risk Manag. 2007 October; 3(5): 733–742. PMCID: PMC2291317 Macro- and micronutrients in patients with congestive heart failure, particularly African-Americans Kevin P Newman, Syamal K Bhattacharya, Ahmad Munir, Richard C Davis, Judith E Soberman, and Kodangudi B Ramanathan Vasc Health Risk Manag. 2007 October; 3(5): 743–747. PMCID: PMC2291318 Original Research Determinants of outcome in patients eligible for thrombolysis for ischemic stroke Valeria Caso, Maurizio Paciaroni, Michele Venti, Francesco Palmerini, Giorgio Silvestrelli, Paolo Milia, Sergio Biagini, and Giancarlo Agnelli Vasc Health Risk Manag. 2007 October; 3(5): 749–754. PMCID: PMC2291319 Is general anesthesia a risk for myocardium? Effect of anesthesia on myocardial function as assessed by cardiac troponin-i in two different groups (isofluran+N2O inhalation and propofol+fentanyl iv anesthesia) Demet Dogan Erol and Ibrahim Ozen Vasc Health Risk Manag. 2007 October; 3(5): 755–758. PMCID: PMC2291320 Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting Brandon A Van Noord, Andrew H Lin, and Jeffery J Cavendish Vasc Health Risk Manag. 2007 October; 3(5): 759–762. PMCID: PMC2291321 Magnetic resonance imaging in coronary artery bypass surgery – improvement of global and segmental function in patients with severely compromized left ventricular function Matthias Thielmann, Peter Hunold, Claudia Böhm, Parwis Massoudy, and Heinz Jakob Vasc Health Risk Manag. 2007 October; 3(5): 763–768. PMCID: PMC2291322 Case Reports Emergency endovascular repair of acute descending thoracic aortic dissection Muhammad Anees Sharif, Mark Edward O’Donnell, Paul Henry Blair, and Peter Kennedy Vasc Health Risk Manag. 2007 October; 3(5): 769–773. PMCID: PMC2291323 Acute coronary syndrome associated with Churg-Strauss syndrome Annette Doris Wagner, Gerd Peter Meyer, Markus Rihl, Anke Rathmann, Ulrike Wittkop, Henning Zeidler, Hermann Haller, and Joachim Lotz Vasc Health Risk Manag. 2007 October; 3(5): 775–779. PMCID: PMC2291324 ISVH Society News ISVH Society September Newsletter W.C. Roberts, A. Zanchetti, R. Asmar, J. Cameron, A. Achimastos, E. Agabiti-Rosei, J. Cockcroft, D. Duprez, J. Filipovsky, J. Izzo, A. Nicolaides, R. Sa Cunha, H. Struijker-Boudier, K. Takazawa, L. Van Bortel, H. Wang, A. Benetos, C. Calvo, J.N. Cohn, K. Cruickshank, P. de Leeuw, N. de Luca, N. Feely, S. Franklin, D. Kass, B. Kingwell, K.K. Koh, S. Laurent, G. Mitchell, J. Palma-Gamiz, B. Pannier, C.G. Park, J. Polonia, C. Rajkumar, E. Schiffrin, A. Scuteri, Y. Sirenko, J. Topouchian, J. Toto-Moukouo, W. Van Meighem, and B. Waeber Vasc Health Risk Manag. 2007 October; 3(5): 781. PMCID: PMC2291448 |